VIRI Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response...

Stats
Dagens volum	67 903.00
Gjennomsnittsvolum	301 361
Markedsverdi	7.92M
EPS	$0 ( 2024-03-12 )
Neste inntjeningsdato	( $-0.0800 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.470
ATR14	$0.00500 (1.21%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-26	Pridgen William	Buy	2 917	Stock Option (right to buy)
2024-02-26	Thomas John C	Buy	4 167	Stock Option (right to buy)
2024-02-26	Whitley Richard James	Buy	4 000	Stock Option (right to buy)
2024-02-26	Keefer David R	Buy	4 709	Stock Option (right to buy)
2024-02-26	Burch Richard Alan	Buy	2 917	Stock Option (right to buy)

INSIDER POWER
99.86
Last 92 transactions
Buy: 2 833 595 \| Sell: 299 106

Volum Korrelasjon

Lang: -0.26 (neutral)

Kort: 0.86 (strong)

Signal:(45.48) Same movement expected

Virios Therapeutics, LLC Korrelasjon

10 Mest positive korrelasjoner
BOCH	0.83
AHPI	0.817
RDI	0.814
SHSP	0.814
ALLK	0.812
MYSZ	0.811
VALN	0.811
LNT	0.803

10 Mest negative korrelasjoner
GLPG	-0.857
NTUS	-0.823
PALT	-0.822
SMMT	-0.82
IDYA	-0.819
TIL	-0.813
DSPG	-0.804
FFNW	-0.804
GAINL	-0.804

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Virios Therapeutics, LLC Korrelasjon - Valuta/Råvare

-0.11
( neutral )

-0.06
( neutral )

0.00
( neutral )

0.39
( neutral )

Virios Therapeutics, LLC Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-0.280

FY	2023
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-0.280

FY	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-1.100

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-3.24

Financial Reports:

No articles found.

Virios Therapeutics, LLC

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia.

Sanntidsoppdatering for Virios Therapeutics, LLC [VIRI]

Upcoming Earnings Alert